125 related articles for article (PubMed ID: 29969578)
1. SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation.
Xiao N; Li H; Yu W; Gu C; Fang H; Peng Y; Mao H; Fang Y; Ni W; Yao M
FASEB J; 2019 Jan; 33(1):163-174. PubMed ID: 29969578
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
Liu Y; Dou X; Zhou WY; Ding M; Liu L; Du RQ; Guo L; Qian SW; Tang Y; Yang QQ; Pan DN; Li XY; Lu Y; Cheng JK; Tang QQ
Hepatology; 2021 Oct; 74(4):1864-1883. PubMed ID: 33934381
[TBL] [Abstract][Full Text] [Related]
3. SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells.
Hu XY; Liu Z; Zhang KL; Feng J; Liu XF; Wang LY; Wang ZW
Cancer Biomark; 2017 Dec; 21(1):195-201. PubMed ID: 29060933
[TBL] [Abstract][Full Text] [Related]
4. SUMO1/sentrin/SMT3 specific peptidase 2 modulates target molecules and its corresponding functions.
Liu SL; Gao FH
Biochimie; 2018 Sep; 152():6-13. PubMed ID: 29908207
[TBL] [Abstract][Full Text] [Related]
5. SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-βRI.
Tan M; Zhang D; Zhang E; Xu D; Liu Z; Qiu J; Fan Y; Shen B
Mol Carcinog; 2017 Oct; 56(10):2332-2341. PubMed ID: 28574613
[TBL] [Abstract][Full Text] [Related]
6. De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis.
Heo KS; Chang E; Le NT; Cushman H; Yeh ET; Fujiwara K; Abe J
Circ Res; 2013 Mar; 112(6):911-23. PubMed ID: 23381569
[TBL] [Abstract][Full Text] [Related]
7. The SUMO-specific protease SENP2 plays an essential role in the regulation of Kv7.2 and Kv7.3 potassium channels.
Chen X; Zhang Y; Ren X; Su Q; Liu Y; Dang X; Qin Y; Yang X; Xing Z; Shen Y; Wang Y; Bai Z; Yeh ETH; Wu H; Qi Y
J Biol Chem; 2021 Oct; 297(4):101183. PubMed ID: 34509475
[TBL] [Abstract][Full Text] [Related]
8. Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2.
Itahana Y; Yeh ET; Zhang Y
Mol Cell Biol; 2006 Jun; 26(12):4675-89. PubMed ID: 16738331
[TBL] [Abstract][Full Text] [Related]
9. An essential role of small ubiquitin-like modifier (SUMO)-specific Protease 2 in myostatin expression and myogenesis.
Qi Y; Zuo Y; Yeh ET; Cheng J
J Biol Chem; 2014 Feb; 289(6):3288-93. PubMed ID: 24344126
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of SENP2-mediated Akt deSUMOylation promotes cardiac regeneration via activating Akt pathway.
Chen Y; Xu T; Li M; Li C; Ma Y; Chen G; Sun Y; Zheng H; Wu G; Liao W; Liao Y; Chen Y; Bin J
Clin Sci (Lond); 2021 Mar; 135(6):811-828. PubMed ID: 33687053
[TBL] [Abstract][Full Text] [Related]
11. SUMO-specific protease 2 suppresses cell migration and invasion through inhibiting the expression of MMP13 in bladder cancer cells.
Tan MY; Mu XY; Liu B; Wang Y; Bao ED; Qiu JX; Fan Y
Cell Physiol Biochem; 2013; 32(3):542-8. PubMed ID: 24008762
[TBL] [Abstract][Full Text] [Related]
12. Mitotic kinase Aurora-B is regulated by SUMO-2/3 conjugation/deconjugation during mitosis.
Ban R; Nishida T; Urano T
Genes Cells; 2011 Jun; 16(6):652-69. PubMed ID: 21554500
[TBL] [Abstract][Full Text] [Related]
13. The SUMO-Specific Protease Senp2 Regulates SUMOylation, Expression and Function of Human Organic Anion Transporter 3.
Wang H; You G
Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1293-1301. PubMed ID: 31054272
[TBL] [Abstract][Full Text] [Related]
14. The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease.
Selby TL; Biel N; Varn M; Patel S; Patel A; Hilding L; Ray A; Ross T; Cramblet WT; Moss CR; Lowrey AJ; Bentz GL
Sci Rep; 2019 Jul; 9(1):9523. PubMed ID: 31266997
[TBL] [Abstract][Full Text] [Related]
15. SENP1 and SENP2 affect spatial and temporal control of sumoylation in mitosis.
Cubeñas-Potts C; Goeres JD; Matunis MJ
Mol Biol Cell; 2013 Nov; 24(22):3483-95. PubMed ID: 24048451
[TBL] [Abstract][Full Text] [Related]
16. Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction.
Kim EY; Chen L; Ma Y; Yu W; Chang J; Moskowitz IP; Wang J
J Mol Cell Cardiol; 2012 Mar; 52(3):638-49. PubMed ID: 22155005
[TBL] [Abstract][Full Text] [Related]
17. SENP2 regulates MMP13 expression in a bladder cancer cell line through SUMOylation of TBL1/TBLR1.
Tan M; Gong H; Wang J; Tao L; Xu D; Bao E; Liu Z; Qiu J
Sci Rep; 2015 Sep; 5():13996. PubMed ID: 26369384
[TBL] [Abstract][Full Text] [Related]
18. Engineering pre-SUMO4 as efficient substrate of SENP2.
Liu Y; Kieslich CA; Morikis D; Liao J
Protein Eng Des Sel; 2014 Apr; 27(4):117-26. PubMed ID: 24671712
[TBL] [Abstract][Full Text] [Related]
19. Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function.
Heo KS; Le NT; Cushman HJ; Giancursio CJ; Chang E; Woo CH; Sullivan MA; Taunton J; Yeh ET; Fujiwara K; Abe J
J Clin Invest; 2015 Mar; 125(3):1299-310. PubMed ID: 25689261
[TBL] [Abstract][Full Text] [Related]
20. NF-κB induction of the SUMO protease SENP2: A negative feedback loop to attenuate cell survival response to genotoxic stress.
Lee MH; Mabb AM; Gill GB; Yeh ET; Miyamoto S
Mol Cell; 2011 Jul; 43(2):180-91. PubMed ID: 21777808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]